Geovax Labs Inc (GOVX) financial statements (2021 and earlier)

Company profile

Business Address 1900 LAKE PARK DRIVE
SMYRNA, GA 30080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10000011
Cash and cash equivalents10000011
Other undisclosed current assets0000000
Total current assets:10010111
Noncurrent Assets
Property, plant and equipment0000000
Other noncurrent assets    000
Other undisclosed noncurrent assets0000   
Total noncurrent assets:0000000
TOTAL ASSETS:10010111
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1211000
Accounts payable0000000
Accrued liabilities0211000
Debt000    
Due to related parties     00
Total current liabilities:1221000
Noncurrent Liabilities
Long-term debt and lease obligation000    
Long-term debt, excluding current maturities000    
Total noncurrent liabilities:000    
Total liabilities:1221000
Stockholders' equity
Stockholders' equity attributable to parent, including:10(2)(1)(0)011
Preferred stock02    0
Common stock0000000
Additional paid in capital55393736353331
Accumulated deficit(46)(43)(40)(38)(36)(32) 
Other undisclosed stockholders' equity attributable to parent  2211(30)
Total stockholders' equity:10(2)(1)(0)011
TOTAL LIABILITIES AND EQUITY:10010111

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net1101
Gross profit:2111101
Operating expenses(5)(4)(4)(3)(4)(3)(4)
Operating loss:(3)(2)(3)(2)(3)(3)(3)
Nonoperating income (expense)(0)000000
Investment income, nonoperating0000000
Interest and debt expense(0)(0)(0)    
Net loss:(3)(2)(3)(2)(3)(3)(3)
Other undisclosed net income attributable to parent000    
Net loss available to common stockholders, diluted:(3)(2)(3)(2)(3)(3)(3)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(3)(2)(3)(2)(3)(3)(3)
Comprehensive loss, net of tax, attributable to parent:(3)(2)(3)(2)(3)(3)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: